Venture Capital Investors

Three Arch Partners

Three Arch Partners is focused on making venture capital investments in good companies that are leveraging tech to solve important problems.

Venture Investor Overview

Venture Investor
Three Arch Partners
Status
InActive
Investor Type
Venture Capital
Activity Level
105 transactions
Funds Raised
Unknown
Industry Focus
Medical Devices & Instruments

Contact Information

Contact
Mark Wan
Title
Founding Partner
Mailing Address
19 South B St. 14
San Mateo, CA 94401
USA
Phone
(650) 529-8000
Website
www.threearchpartners.com
Email Address
[email protected]

Background Information

Overview
Three Arch Partners invests only in healthcare. They consider opportunities in Medical Devices & Instruments, diagnostics and healthcare services, and less frequently in biotechnology. Their primary focus is on early stage investments, where the right team and approach can generate the best returns. They also make selected investments in later stage healthcare companies that can benefit from their experience and resources and promise strong financial returns.
Profile
Three Arch Partners LinkedIn Company Profile
Social Media
Three Arch Partners Company Twitter Account
Company News
Three Arch Partners News
Facebook
Three Arch Partners on Facebook
YouTube
Three Arch Partners on YouTube
Last Transaction
6/7/2017

Transaction History

Our records indicate that Three Arch Partners invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Neuronetics
6/7/2017
$15,000,000
Ocera Therapeutics
7/17/2013
$20,000,000
Nevro
3/7/2013
$48,000,000
AccessClosure
3/31/2012
$2,795,000
Inova Labs
11/9/2011
$17,500,000
Nevro
7/20/2011
$58,000,000
Crux Biomedical
6/30/2011
$12,000,000
Neuronetics
5/16/2011
$30,000,000
VisionCare Ophthalmic Technologies
1/10/2011
$31,000,000
Calistoga Pharmaceuticals
12/31/2010
$5,719,000
TriReme Medical
10/11/2010
$17,000,000
Calistoga Pharmaceuticals
6/30/2010
$40,000,000
Voyage Medical
6/30/2010
$20,600,000
Baxano
6/22/2010
$30,000,000
Inova Labs
5/20/2010
$10,000,000
AccessClosure
3/31/2010
Unknown
AcelRx Pharmaceuticals
12/31/2009
$14,814,000
TriReme Medical
12/31/2009
$7,055,100
Calistoga Pharmaceuticals
12/31/2009
Unknown
Calibra Medical
11/24/2009
$1,400,000
VisionCare Ophthalmic Technologies
9/30/2009
Unknown
SpinalMotion
9/30/2009
Unknown
Satiety
9/30/2009
$25,300,000
Novasys Medical
7/21/2009
$18,950,000
AscendHealth
6/30/2009
$3,950,000
Calistoga Pharmaceuticals
5/5/2009
$30,000,000
Visiogen
4/27/2009
$40,000,000
Spiration
12/31/2008
$884,000
TriReme Medical
12/31/2008
$4,998,000
Centerre Healthcare
12/31/2008
$5,000,000
WaveRx
12/31/2008
Unknown
Arete Therapeutics
11/19/2008
$16,700,000
APT Pharmaceuticals
9/30/2008
$32,000,000
Baxano
9/2/2008
$20,000,000
Voyage Medical
7/29/2008
$20,000,000
Eleme Medical
7/16/2008
$18,000,000
Cameron Health
6/16/2008
$51,500,000
Novasys Medical
5/16/2008
$49,500,000
Seattle Medical Technologies
5/2/2008
$21,000,000
Concert Pharmaceuticals
4/30/2008
$37,000,000
AcelRx Pharmaceuticals
3/31/2008
$20,218,100
Spiration
3/25/2008
$18,500,000
Cameron Health
3/15/2008
$14,100,000
HemoSphere
2/20/2008
$12,000,000
Arbor Surgical Technologies
1/30/2008
$20,000,000
Benvenue Medical
1/7/2008
$15,000,000
Calistoga Pharmaceuticals
1/3/2008
$5,200,000
Calistoga Pharmaceuticals
12/31/2007
$15,735,000
Access Sports Media
12/31/2007
$35,000,000
TriReme Medical
10/17/2007
$15,500,000
Satiety
7/17/2007
$30,000,000
Access Sports Media
6/30/2007
$1,554,000
Arete Therapeutics
5/23/2007
$13,300,000
NeuroVista
5/10/2007
$33,800,000
Synovis Orthopedic and Woundcare
5/10/2007
$20,000,000
SquareOne
5/2/2007
$7,500,000
Reliance Communications
4/19/2007
$15,000,000
Seattle Medical Technologies
3/31/2007
Unknown
SmoothShapes
3/13/2007
$15,000,000
Calistoga Pharmaceuticals
3/6/2007
$21,000,000
Visiogen
3/1/2007
$24,000,000
Baxano
1/22/2007
$8,500,000
AscendHealth
12/31/2006
$20,100,000
NBI Development
12/4/2006
$5,500,000
Concert Pharmaceuticals
11/30/2006
$48,500,000
Neuronetics
9/30/2006
$35,000,200
Seattle Medical Technologies
9/30/2006
$8,349,900
AcelRx Pharmaceuticals
9/30/2006
Unknown
WaveRx
9/30/2006
$2,998,000
Acorn Cardiovascular
9/30/2006
$4,000,000
SpinalMotion
9/27/2006
$20,000,000
LipoScience
8/15/2006
$13,000,000
Concert Pharmaceuticals
7/17/2006
$10,000,000
Cameron Health
6/30/2006
$31,255,000
Triple Point Medical
6/30/2006
$399,900
Seattle Medical Technologies
6/30/2006
$250,000
Concuity
4/26/2006
$2,500,000
Sirtris Pharmaceuticals
4/20/2006
$37,000,000
Spiration
4/3/2006
$13,400,000
VeinRX
3/31/2006
$5,998,000
MetricVision
3/31/2006
$4,000,300
Access Sports Media
3/31/2006
$30,000,000
Reliance Communications
3/13/2006
$22,000,000
Arcadian Management Services
9/30/2005
$19,000,100
Arbor Surgical Technologies
8/22/2005
$20,000,000
AcuFocus
6/30/2005
$27,500,000
Satiety
6/30/2005
$14,265,000
Vivant Medical
6/30/2005
Unknown
AscendHealth
6/30/2005
$2,600,000
Seattle Medical Technologies
6/30/2005
$500,000
AccentCare
6/30/2005
$13,900,000
WaveRx
6/30/2005
$3,000,100
Synovis Orthopedic and Woundcare
6/8/2005
$10,000,000
Sirtris Pharmaceuticals
3/31/2005
$27,000,000
Visiogen
3/31/2005
$8,250,000
Neuronetics
3/31/2005
$8,500,200
SpinalMotion
3/31/2005
$20,110,000
VisionCare Ophthalmic Technologies
3/7/2005
$20,000,000
Arete Therapeutics
2/21/2005
$15,000,000
Concuity
10/19/2004
$8,300,000
Evalve
5/24/2004
$35,000,000
Threshold Pharmaceuticals
1/12/2004
$41,000,000
Spiration
1/6/2004
$26,900,000
AccentCare
5/31/2003
$5,000,000
Vascular Architects
1/6/2003
$16,000,000

 

Investor Contacts

Title
Name
Email & Social
Partner
Wilfred Jaeger
  Wilfred Jaeger LinkedIn Profile  Wilfred Jaeger Twitter Account  Wilfred Jaeger News  Wilfred Jaeger on Facebook
Partner
Mark Wan
  Mark Wan LinkedIn Profile  Mark Wan Twitter Account  Mark Wan News  Mark Wan on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

Three Arch Partners has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
AccentCare
Access Sports Media
AccessClosure
AcelRx Pharmaceuticals
Acorn Cardiovascular
AcuFocus
APT Pharmaceuticals
Arbor Surgical Technologies
Arcadian Management Services
Arete Therapeutics
AscendHealth
Baxano
Benvenue Medical
Calibra Medical
Calistoga Pharmaceuticals
Cameron Health
Centerre Healthcare
Concert Pharmaceuticals
Concuity
Crux Biomedical
Eleme Medical
Evalve
HemoSphere
Inova Labs
LipoScience
MetricVision
NBI Development
Neuronetics
NeuroVista
Nevro
Novasys Medical
Ocera Therapeutics
Reliance Communications
Satiety
Seattle Medical Technologies
Sirtris Pharmaceuticals
SmoothShapes
SpinalMotion
Spiration
SquareOne
Synovis Orthopedic and Woundcare
Threshold Pharmaceuticals
Triple Point Medical
TriReme Medical
Vascular Architects
VeinRX
Visiogen
VisionCare Ophthalmic Technologies
Vivant Medical
Voyage Medical
WaveRx

 

 

 

 

Browse more venture capital investors:

Thorney Group | Three Arrows Capital

 

Share this article

 

About Our Venture Capital Investor Database

The venture capital investor data above is provided by VentureDeal.com, a market leader in private equity transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.